Oral Abstract Session:
042. The Cutting Edge in Antimicrobial Resistance Emergence Therapy
Thursday, October 5, 2017: 10:30 AM-12:00 PM
Room: 01AB

Tracks: Pediatric ID, Investigative ID, Epidemiology and Infection Control, Adult ID, Trainee

Moderators:  Warren Rose, PharmD, MPH, University of Wisconsin-Madison and Cesar Arias, MD, PhD, FIDSA, University of Texas McGovern Medical School

10:30 AM
SYN-004 (ribaxamase) prevents New Onset Clostridium difficile Infection by Protecting the Integrity Gut Microbiome in a Phase 2b Study
John Kokai-Kun, PhD; Tracey Roberts, BSN; Olivia Coughlin, PhD; Heidi Whalen, MHS; Charles Le, PhD; Christopher Da Costa, MD; Joseph Sliman, MD, PhD
11:00 AM
Cefazolin plus Clavulanic Acid Overcomes the Inoculum Effect in a Methicillin-Susceptible Staphylococcus aureus (MSSA) Rat Endocarditis Model
William Miller, MD; Kavindra Singh, Ph.D.; Cesar Arias, MD, PhD, FIDSA; Barbara Murray, MD, FIDSA
11:15 AM
Epidemiology of Inappropriate Empiric Antibiotic Therapy for Bacteremia Based on Discordant In vitro Susceptibilities: Risk factors and Taxon-level Variation in Burden and Outcome in 156 US hospitals, 2000-2014
Sameer S. Kadri, MD, MS; Yi Ling Lai, MPH; Emily Ricotta, PhD, ScM; Jeffrey Strich, MD; Ahmed Babiker, MBBS; John P. Dekker, M.D., Ph.D.; Tara Palmore, MD; Chanu Rhee, MD, MPH; Michael Klompas, MD, MPH, FRCPC, FIDSA; David C. Hooper, MD; John H. Powers III, MD; Robert L. Danner, MD; Jennifer Adjemian, PhD
11:30 AM
Evolution of antibiotic tolerance during oxacillin, daptomycin and dalbavancin therapy results in breakthrough Staphylococcus aureus bacteremias
Andrew Berti, PharmD PhD; Jeremy Schroeder, PhD; Aaron Rottier, Undergraduate; Sue McCrone, Staff Scientist; Jade Wang, PhD; Warren Rose, PharmD, MPH
11:45 AM
Carbapenem-resistant Enterobacteriaceae (CRE) or Delayed Appropriate Therapy (DAT)—Does One Affect Outcomes More Than the Other Among Patients With Serious Infections Due to Enterobacteriaceae?
Thomas Lodise, PharmD, PhD; Ariel Berger, MPH; Arman Altincatal, MS; Rosa Wang, MHA; Tarun Bhagnani, MS; Patrick Gillard, PharmD; Nicole G. Bonine, PhD, MPH

CME Credits: No CME credit is offered for this session.

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.